Fenclozic Acid

CHEMBL1909282 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
253.7 g/mol
LogP
2.7
Phase
4

This anti-inflammatory compound inhibits prostaglandin synthesis and was investigated for the treatment of arthritis. It has limited current clinical use.

Masse moléculaire

253,7100 g/mol

LogP

2,70

TPSA

78,40 Ų

Règle des 5 de Lipinski

Conforme

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(O)Cc1csc(-c2ccc(Cl)cc2)n1

InChI

InChI=1S/C11H8ClNO2S/c12-8-3-1-7(2-4-8)11-13-9(6-16-11)5-10(14)15/h1-4,6H,5H2,(H,14,15)

Molecular Formula

C11H8ClNO2S

HBD / HBA

1 / 4

Liaisons Rotatives

3

Atomes Lourds

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This anti-inflammatory compound inhibits prostaglandin synthesis and was investigated for the treatment of arthritis. It has limited current clinical use.

Yes, Fenclozic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1909282. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 28858. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.